Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Multiple Sclerosis Centers of Excellence

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Videos on Multiple Sclerosis Symptoms and Management

The videos below are recorded from our live MSCoE satellittes for VA healthcare professionals. Each video contains important information about MS symptoms and managing the symptoms of the disease. Videos contain 20-30 minutes of vignettes from Veterans living with MS.

Bowel and Bladder Issues in Patients with MS

Bladder dysfunction is experienced by over 80% of people with MS. This video discusses how the bladder and bowel systems function, as well as how MS lesion damage can disrupt normal functioning. Non-pharmacologic, pharmacologic, and surgical methods to treat dysfunction as well as techniques for self-management are also discussed. (1 hour, 29 minutes)
Presenters: Nina Davis, MD; Peter Gorman, MD; Heidi Maloni, PhD, APRN, ANP, MSCN

Mobility for People with Early-Transitional MS

Difficulty with walking is among the most common mobility limitation in MS. This can be related to spasticity, balance, sensory deficit, fatigue, or muscle weakness. Mobility issues, evaluation of mobility changes, and strategies for maintaining mobility are discussed in this video. (1 hour, 29 minutes)
Presenters: Michelle Cameron, MD, PT, MCR; Janet Powell, PhD, ORT/L; Pat Provance, PT, MSCS

MS and Emotional Disorders: Approach to Management

MS can have a profound impact on one's emotional state of mind, with common emotional changes being grief, worry, fear, moodiness, irritability, depression, and anxiety. Knowing how to recognize emotional changes and get help is important. Types of mental and emotional disorders, therapeutic interventions, communication techniques, and skills to manage home and work life are discussed in this video. (1 hour, 26 minutes)
Presenters: Sarah Minden, MD; Aaron Turner, PhD

MS, Cognition, and Brain Imaging: Understanding Cognitive Dysfunction

Cognitive changes are a common symptom of MS, with more than half of all people with MS developing problems with cognition. This video discusses how cognitive problems are identified, the brain structures and functions related to cognition, and interventions and rehabilitation strategies to enhance cognitive functioning. (1 hour, 28 minutes)
Presenters: Stephen Rao, PhD; Aaron Turner, PhD

MS Modifiable Risk Factors

While researchers know a lot about the mechanism of MS, they are still trying to understand its cause. There are a number of factors that may increase a person's risk of getting MS and a number of factors that may make a symptom worse. Modifiable risk factors, including vitamin D, vaccines, smoking, nutrition, alcohol consumption, stress, and exercise, are discussed in this video along with mechanisms for modifying behavior. (1 hour, 42 minutes)
Presenters: Heidi Maloni, PhD, APRN, ANP, MSCN; Aaron Turner, PhD; Walter Royal, III, MD

Pain and Palliative Care for People with MS

Experiences with pain are common for people with MS, ranging from acute to chronic. This video describes the prevalence and factors associated with pain, experience of pain, and pharmacological and non-pharmacological management of pain in MS. (1 hour, 29 minutes)
Presenters: David Gruenewald, MD; Jodie Haselkorn, MD, MPH; Heidi Maloni, PhD, APRN, BC-ANP, CNRN, MSCN; Dawn Ehde, PhD

Sexual Intimacy and MS

Sexual problems are often experience by people with MS since sexual arousal begins in the central nervous system, as the brain sends messages to the sexual organs. Types of sexual problems will be discussed in this video as well as contributing factors to sexual problems and pharmacological and non-pharmacological management options. (1 hour, 46 minutes)
Presenters: Jodie Haselkorn, MD, MPH; Scott Litwiller, MD; Deborah Miller, PhD, LISW

Wheeled Mobility in MS

A transition to mobility assistance may be necessary as MS progresses. Advanced mobility impairment, the team approach to managing mobility impairment, the wide variety of mobility devices, and the importance of matching assistive technologies to specific individuals is discussed in this video. (1 hour, 42 minutes)
Presenters: Rory Cooper, PhD; Rosemarie Cooper, MPT, ATP; Jodie Haselkorn, MD, MPH


MS Disease Modifying Therapies

Medications are used in MS to modify the disease course, reducing the number of relapses, delaying progression of disability, and limited new disease activity (as seen on MRI). This video discusses the various FDA approved disease modifying therapies for MS. Discussions include DMT routes of delivery, efficacy, and side effects as well as complexity of choice and monitoring.

Part 1: Introduction to DMT's
  • MS definition, symptoms, and disease subtypes
  • DMT goals, classifications, and routes of delivery           
  • VA National Formulary process
  • DMT considerations
Part 2: Injection DMT's
  • Beta-1a (Avonex, Rebif)
  • Beta-1b (Betaseron, Extavia)
  • Pegylated beta-1a (Plegridy)
  • Glatiramer acetate (Copaxone)
Part 3: Infusion DMT's
  • Mitoxantrone (Novantrone)
  • Natalizumab (Tysabri)
  • Alemtuzumab (Lemtrada)
Part 4: Oral DMT's
  • Teriflunomide (Augabio)
  • Dimethyl Fumurate (Tecfidera)
  • Fingolimod (Gilenya)
Part 5: DMT Considerations
  • DMT considerations
  • DMT selection considerations
  • Screening and monitoring